Abstract
We present a case of tuberculous peritonitis in a 71-year-old woman with long-standing rheumatoid arthritis treated with adalimumab, and we review the association between antitumor necrosis factor therapy and tuberculosis. Our case illustrates that the index of suspicion of tuberculosis in these patients, even with atypical clinical features, must be very high, and underscores the need of tuberculosis screening before therapy is started.
References
Olsen NJ, Stein CM (2004) New drugs for rheumatoid arthritis. N Engl J Med 350:2167–2179
Bieber J, Kavanaugh A (2004) Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments. Rheum Dis Clin North Am 30:257–270
Rychly DJ, Dipiro JT (2005) Infections associated with tumor necrosis factor-alpha antagonists. Pharmacotherapy 25:1181–1192
Scheinfeld N (2005) Adalimumab: a review of side effects. Expert Opin Drug Saf 4:637–641
Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor a-neutralizing agent. N Engl J Med 345:1098–1104
Mohan AK, Coté TR, Block JA, Manadan AM, Siegel JN, Braun MM (2004) Tuberculosis following the use of etarnecept, a tumor necrosis factor inhibitor. Clin Infect Dis 39:295–299
Wallis RS, Broder MS, Wong JY, Hanson ME, Beenouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261–1265
Carmona L, Hernández-García C, Vadillo C, Pato E, Balsa A, González-Alvaro I, EMECAR Study Group (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30:1436–1439
Manadan AM, Block JA, Sequeira W (2003) Mycobacteria tuberculosis peritonitis associated with etarnecept therapy. Clin Exp Rheumatol 21:526
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gutiérrez-Macías, A., Lizarralde-Palacios, E., Martínez-Odriozola, P. et al. Tuberculous peritonitis in a patient with rheumatoid arthritis treated with adalimumab. Clin Rheumatol 26, 452–453 (2007). https://doi.org/10.1007/s10067-005-0164-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0164-3